111 related articles for article (PubMed ID: 31053507)
1. Discovery of 5-(5-fluoro-1H-pyrrolo[2,3-b]pyridin-3-yl)pyrazin-2(1H)-one derivatives as new potent PB2 inhibitors.
Yang J; Du J; Huang C; Wang T; Huang L; Yang S; Li L
Bioorg Med Chem Lett; 2019 Jul; 29(13):1609-1613. PubMed ID: 31053507
[TBL] [Abstract][Full Text] [Related]
2. A novel small-molecule compound disrupts influenza A virus PB2 cap-binding and inhibits viral replication.
Yuan S; Chu H; Zhang K; Ye J; Singh K; Kao RY; Chow BK; Zhou J; Zheng BJ
J Antimicrob Chemother; 2016 Sep; 71(9):2489-97. PubMed ID: 27272726
[TBL] [Abstract][Full Text] [Related]
3. Discovery of a potent inhibitor targeting the cap-binding domain of the PB2 subunit of influenza RNA-dependent RNA polymerase.
Sun W; Zhang Z; Chen M; Liu X; Wang Y; Yao S; Li L
Biochem Biophys Res Commun; 2023 Oct; 678():97-101. PubMed ID: 37625270
[TBL] [Abstract][Full Text] [Related]
4. Preclinical activity of VX-787, a first-in-class, orally bioavailable inhibitor of the influenza virus polymerase PB2 subunit.
Byrn RA; Jones SM; Bennett HB; Bral C; Clark MP; Jacobs MD; Kwong AD; Ledeboer MW; Leeman JR; McNeil CF; Murcko MA; Nezami A; Perola E; Rijnbrand R; Saxena K; Tsai AW; Zhou Y; Charifson PS
Antimicrob Agents Chemother; 2015 Mar; 59(3):1569-82. PubMed ID: 25547360
[TBL] [Abstract][Full Text] [Related]
5. A Small-Molecule Compound Has Anti-influenza A Virus Activity by Acting as a ''PB2 Inhibitor".
Liu T; Liu M; Chen F; Chen F; Tian Y; Huang Q; Liu S; Yang J
Mol Pharm; 2018 Sep; 15(9):4110-4120. PubMed ID: 30102858
[TBL] [Abstract][Full Text] [Related]
6. Discovery of 5-(4-methylpiperazin-1-yl)-2-nitroaniline derivatives as a new class of SIRT6 inhibitors.
Sun W; Chen X; Huang S; Li W; Tian C; Yang S; Li L
Bioorg Med Chem Lett; 2020 Aug; 30(16):127215. PubMed ID: 32631504
[TBL] [Abstract][Full Text] [Related]
7. Influenza A virus polymerase: an attractive target for next-generation anti-influenza therapeutics.
Zhou Z; Liu T; Zhang J; Zhan P; Liu X
Drug Discov Today; 2018 Mar; 23(3):503-518. PubMed ID: 29339107
[TBL] [Abstract][Full Text] [Related]
8. Identification of influenza polymerase inhibitors targeting polymerase PB2 cap-binding domain through virtual screening.
Liu M; Lo CY; Wang G; Chow HF; Ngo JC; Wan DC; Poon LL; Shaw PC
Antiviral Res; 2017 Aug; 144():186-195. PubMed ID: 28629986
[TBL] [Abstract][Full Text] [Related]
9. Approaches for discovery of small-molecular antivirals targeting to influenza A virus PB2 subunit.
Chen W; Shao J; Ying Z; Du Y; Yu Y
Drug Discov Today; 2022 Jun; 27(6):1545-1553. PubMed ID: 35247593
[TBL] [Abstract][Full Text] [Related]
10. New 7-methylguanine derivatives targeting the influenza polymerase PB2 cap-binding domain.
Pautus S; Sehr P; Lewis J; Fortuné A; Wolkerstorfer A; Szolar O; Guilligay D; Lunardi T; Décout JL; Cusack S
J Med Chem; 2013 Nov; 56(21):8915-30. PubMed ID: 24134208
[TBL] [Abstract][Full Text] [Related]
11. Identification of a novel small-molecule compound targeting the influenza A virus polymerase PB1-PB2 interface.
Yuan S; Chu H; Ye J; Singh K; Ye Z; Zhao H; Kao RY; Chow BK; Zhou J; Zheng BJ
Antiviral Res; 2017 Jan; 137():58-66. PubMed ID: 27840201
[TBL] [Abstract][Full Text] [Related]
12. Focusing on the Influenza Virus Polymerase Complex: Recent Progress in Drug Discovery and Assay Development.
Zhang J; Hu Y; Musharrafieh R; Yin H; Wang J
Curr Med Chem; 2019; 26(13):2243-2263. PubMed ID: 29984646
[TBL] [Abstract][Full Text] [Related]
13. Probing the impact of quercetin-7-O-glucoside on influenza virus replication influence.
Gansukh E; Kazibwe Z; Pandurangan M; Judy G; Kim DH
Phytomedicine; 2016 Aug; 23(9):958-67. PubMed ID: 27387404
[TBL] [Abstract][Full Text] [Related]
14. Design, Synthesis, Biological Evaluation, and Molecular Dynamics Simulation of Influenza Polymerase PB2 Inhibitors.
Li X; Xu Y; Li W; Che J; Zhao X; Cao R; Li X; Li S
Molecules; 2023 Feb; 28(4):. PubMed ID: 36838837
[TBL] [Abstract][Full Text] [Related]
15. Design, synthesis and biological evaluation of novel, orally bioavailable pyrimidine-fused heterocycles as influenza PB2 inhibitors.
Xiong J; Wang J; Hu G; Zhao W; Li J
Eur J Med Chem; 2019 Jan; 162():249-265. PubMed ID: 30448415
[TBL] [Abstract][Full Text] [Related]
16. Identification of influenza polymerase inhibitors targeting C-terminal domain of PA through surface plasmon resonance screening.
Lo CY; Li OT; Tang WP; Hu C; Wang GX; Ngo JC; Wan DC; Poon LL; Shaw PC
Sci Rep; 2018 Feb; 8(1):2280. PubMed ID: 29396435
[TBL] [Abstract][Full Text] [Related]
17. Synthesis and inhibitory effects of novel pyrimido-pyrrolo-quinoxalinedione analogues targeting nucleoproteins of influenza A virus H1N1.
Lin MI; Su BH; Lee CH; Wang ST; Wu WC; Dangate P; Wang SY; Huang WI; Cheng TJ; Lin OA; Cheng YS; Tseng YJ; Sun CM
Eur J Med Chem; 2015 Sep; 102():477-86. PubMed ID: 26310893
[TBL] [Abstract][Full Text] [Related]
18. Design and synthesis of 2-((1H-indol-3-yl)thio)-N-phenyl-acetamides as novel dual inhibitors of respiratory syncytial virus and influenza virus A.
Zhang GN; Li Q; Zhao J; Zhang X; Xu Z; Wang Y; Fu Y; Shan Q; Zheng Y; Wang J; Zhu M; Li Z; Cen S; He J; Wang Y
Eur J Med Chem; 2020 Jan; 186():111861. PubMed ID: 31734025
[TBL] [Abstract][Full Text] [Related]
19. 9-Aminoacridine-based agents impair the bovine viral diarrhea virus (BVDV) replication targeting the RNA-dependent RNA polymerase (RdRp).
Loddo R; Francesconi V; Laurini E; Boccardo S; Aulic S; Fermeglia M; Pricl S; Tonelli M
Bioorg Med Chem; 2018 Feb; 26(4):855-868. PubMed ID: 29325885
[TBL] [Abstract][Full Text] [Related]
20. Design, synthesis, and docking studies of phenylpicolinamide derivatives bearing 1H-pyrrolo[2,3-b]pyridine moiety as c-Met inhibitors.
Zhu W; Wang W; Xu S; Tang Q; Luo R; Wang M; Gong P; Zheng P
Bioorg Med Chem; 2016 Feb; 24(4):812-9. PubMed ID: 26810712
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
